LENNON DAVID JAMES (CHIEF EXECUTIVE OFFICER) sold 2.7% of their position (14.50K shares) of WHITEHAWK THERAPEUTICS, INC. on the open market
Open‑market sale worth $49.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/10/2026ACC: 0001995275-26-000012
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Mar 2026
-14.50K
Net shares
Net seller
$49.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
14.50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−14.50K
Price / share
$3.38
Trade value
$49.01K
% of position
2.7%
4/9/2026
533.12K→518.62K
Total
Net shares
−14.50K
Net value
-$49.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/9/2026 | S · Sale | −14.50K | $3.38 | $49.01K | 2.7% | 533.12K | 518.62K |
| Total | −14.50K | -$49.01K | ||||||
Derivative Transactions0
No derivative transactions reported